David Dornan

Chief Scientific Officer, Bolt Biotherapeutics, Inc.

Companies

Whitehawk Therapeutics, Inc.Chief Scientific Officer Feb 18, 2025 to now¹
Elevation Oncology, Inc.Chief Scientific Officer Mar 16, 2022 to now²
Bolt Biotherapeutics, Inc.Chief Scientific Officer Feb 4, 2021 to Feb 23, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Elevation Oncology, Inc.5,223 shares⁴Feb 15, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 15, 2025Shares withheld for tax 4,152 shares at $0.67 of Elevation Oncology, Inc.⁴
Feb 15, 2025Exercised options 9,375 shares of Elevation Oncology, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARWhitehawk Therapeutics, Inc., Chief Scientific Officer
2
SEC EDGARElevation Oncology, Inc., Chief Scientific Officer
3
SEC EDGARBolt Biotherapeutics, Inc., Chief Scientific Officer
4
SEC EDGARElevation Oncology, Inc. shares after the filing of Feb 15, 2025